Evidence map›Paper›PMID 40605934›Full record

ArticleBMC artificial intelligence2025

End-to-end prediction of clinical outcomes in head and neck squamous cell carcinoma with foundation model-based multiple instance learning.

Asier Rabasco Meneghetti, Marta Ligero Hernández, Jens-Peter Kühn, Steffen Löck, Zunamys Itzell Carrero, Raquel Perez-Lopez, Keno K Bressem, Titus J Brinker, Alexander T Pearson, Daniel Truhn and 2 more

Abstract read
In one paragraph

Article in BMC artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Asier Rabasco MeneghettiElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, 01307 Germany.
Marta Ligero HernándezElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, 01307 Germany.
Jens-Peter KühnInstitute and Policlinic for Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Steffen LöckGerman Cancer Consortium (DKTK), Partner Site Dresden, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Zunamys Itzell CarreroElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, 01307 Germany.
Raquel Perez-LopezRadiomics Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
Keno K BressemDepartment of Diagnostic and Interventional Radiology, Technical University of Munich, School of Medicine and Health, Klinikum Rechts Der Isar, TUM University Hospital, Ismaninger Str. 22, Munich, 81675 Germany.
Titus J BrinkerDigital Biomarkers for Oncology Group, German Cancer Research Center (DKFZ), INF 223, Heidelberg, 69120 Germany.
Alexander T PearsonSection of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL USA.
Daniel TruhnDepartment of Diagnostic and Interventional Radiology, Medical Faculty, RWTH Aachen University, Aachen, 52074 Germany.
Sven NebelungElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, 01307 Germany.
Jakob Nikolas KatherElse Kroener Fresenius Center for Digital Health, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, 01307 Germany.

Funding

Integration of epidemiology, pathology, immunology and outcomes in colorectal cancerR01CA263318 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI STEPHEN B GRUBER · 2022 to 2026
$3.4M
NCI NIH HHS R01 CA263318
6 · The paper itself

Abstract

Background: Foundation models have shown promise in medical AI by learning flexible features from large datasets, offering new opportunities for improving endpoint prediction. However, usage of foundation models for endpoint prediction using routine imaging in head and neck squamous cell carcinoma patients remains unexplored. Within this study, we evaluated the potential of foundation-model based multiple instance learning for prediction of 2-year overall survival, locoregional control and freedom from distant metastasis across three external head and neck squamous cell carcinoma patient cohorts using 2D, multiview and 3D approaches while comparing prediction and stratification performance with handcrafted radiomics and clinical baselines. Results: 2D multiple-instance learning models achieved 2-year test area under the receiver-operator curve (AUROC) range of 0.75-0.84 for 2-year overall survival, 0.66-0.75 for 2-year locoregional control and 0.71-0.78 for 2-year freedom from distant metastasis across three different external cohorts, outperforming multiview and 3D multiple instance learning models (AUROC range: 0.50-0.77, p Conclusions: FM-based 2D MIL demonstrates promise in HNSCC risk prediction as well as stratification of clinical outcomes. The models match or outperform radiomics baselines, learning clinically-related patterns and showing enhancement of clinical baselines in non-human papilloma virus positive patients. Supplementary Information: The online version contains supplementary material available at 10.1186/s44398-025-00003-8.

Indexed as

Foundation modelsHead and neck cancerMultimodalityPrognosisRadiomics

Identifiers

PMID40605934
PMCPMC12212421

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.